POSEIDA THERAPEUTICS INC.

In News

Poseida Therapeutics, Inc. Announces Agreement to be Acquired by Roche Holdings, Inc. - PR Newswire

PR Newswire - Nov 26, 2024

CAR T-Cell Therapy for Multiple Myeloma Market to Witness - GlobeNewswire

GlobeNewswire - Oct 08, 2025

Roche makes takeover bid for Poseida Therapeutics Inc - European Biotechnology Magazine

European Biotechnology Magazine - Nov 26, 2024

Roche Nears Completion of Poseida Acquisition Worth Up to $1.5B - BioSpace

BioSpace - Jan 08, 2025

Major pharmaceutical company Roche buys cell and gene developer Poseida Therapeutics in $1.5 billion acquisition - BioProcess International

BioProcess International - Jan 08, 2025

Roche to Acquire Poseida Therapeutics in a Deal Worth Up to $1.5 Billion - WSJ - The Wall Street Journal

The Wall Street Journal - Nov 26, 2024

Roche to acquire Poseida Therapeutics for $1.5bn - Pharmaceutical Technology

Pharmaceutical Technology - Nov 26, 2024

Roche to complete $1.5 billion acquisition of U.S. biopharma company Poseida - Reuters

Reuters - Jan 08, 2025

Roche to buy cell therapy developer Poseida for $1B - BioPharma Dive

BioPharma Dive - Nov 26, 2024

Roche Agrees to Acquire Poseida Therapeutics - Contract Pharma

Contract Pharma - Dec 02, 2024

Astellas and Poseida Therapeutics Announce Strategic Investment to Support Poseida's Commitment to Redefining Cancer Cell Therapy - PR Newswire

PR Newswire - Aug 07, 2023

Ikena Oncology and Inmagene Biopharmaceuticals Announce - GlobeNewswire

GlobeNewswire - Jul 23, 2025

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment